Home Sulfos 9H-Carbazole-9-propanoic acid, 3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-, (3R)-

9H-Carbazole-9-propanoic acid, 3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-, (3R)-

CAS No.:
116649-85-5
Catalog Number:
AG000CXU
Molecular Formula:
C21H21FN2O4S
Molecular Weight:
416.4658
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$91
- +
10mg
99%
1 week
United States
$140
- +
50mg
99%
1 week
United States
$348
- +
100mg
99%
1 week
United States
$543
- +
Product Description
Catalog Number:
AG000CXU
Chemical Name:
9H-Carbazole-9-propanoic acid, 3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-, (3R)-
CAS Number:
116649-85-5
Molecular Formula:
C21H21FN2O4S
Molecular Weight:
416.4658
MDL Number:
MFCD00887606
IUPAC Name:
3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid
InChI:
InChI=1S/C21H21FN2O4S/c22-14-5-8-16(9-6-14)29(27,28)23-15-7-10-20-18(13-15)17-3-1-2-4-19(17)24(20)12-11-21(25)26/h1-6,8-9,15,23H,7,10-13H2,(H,25,26)/t15-/m1/s1
InChI Key:
LDXDSHIEDAPSSA-OAHLLOKOSA-N
SMILES:
OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F
UNII:
P1ALI72U6C
Properties
Complexity:
689  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
416.121g/mol
Formal Charge:
0
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
416.467g/mol
Monoisotopic Mass:
416.121g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
96.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.9  
Literature
Title Journal
Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. Neurotoxicology 20131201
Asymmetric chemoenzymatic synthesis of ramatroban using lipases and oxidoreductases. The Journal of organic chemistry 20120518
Induction of apoptosis in non-small cell lung carcinoma A549 cells by PGD₂ metabolite, 15d-PGJ₂. Cell biology international 20111101
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases. Journal of medicinal chemistry 20111027
Zwitterionic CRTh2 antagonists. Journal of medicinal chemistry 20110324
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases. Bioorganic & medicinal chemistry letters 20110101
Prostaglandin D₂ receptor CRTH2 antagonists for the treatment of inflammatory diseases. Progress in medicinal chemistry 20110101
Prophylactic effects of the histamine H1 receptor antagonist epinastine and the dual thromboxane A2 receptor and chemoattractant receptor-homologous molecule expressed on Th2 cells antagonist ramatroban on allergic rhinitis model in mice. Biological & pharmaceutical bulletin 20110101
CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue. Allergy 20100301
Identification and characterisation of new inhibitors for the human hematopoietic prostaglandin D2 synthase. European journal of medicinal chemistry 20100201
[CRTH2 antagonist ameliorates airway inflammation in rats with asthma]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20100101
7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists. Bioorganic & medicinal chemistry letters 20090815
Evidence that 13-14 di-hydro, 15-keto prostaglandin D(2)-induced airway eosinophilia in guinea-pigs is independent of interleukin-5. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20090201
IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model. International archives of allergy and immunology 20090101
A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils. European journal of clinical investigation 20080901
CRTH2 plays an essential role in the pathophysiology of Cry j 1-induced pollinosis in mice. Journal of immunology (Baltimore, Md. : 1950) 20080415
Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases. Journal of medicinal chemistry 20080410
The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovascular research 20080401
Antagonists of the prostaglandin D2 receptor CRTH2. Drug news & perspectives 20080101
Participation in cysteinyl leukotrienes and thromboxane A2 in nasal congestion model in Brown Norway rats. International immunopharmacology 20071101
A paracrine role for chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) in mediating chemotactic activation of CRTH2+ CD4+ T helper type 2 lymphocytes. Immunology 20070801
Interactive effect of histamine and prostaglandin D2 on nasal allergic symptoms in rats. European journal of pharmacology 20070112
Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation. Respiratory research 20070101
Successful treatment of eosinophilic otitis media using ramatroban: report of two cases. Auris, nasus, larynx 20061201
Involvement of cyclooxygenase-2 in allergic nasal inflammation in rats. International immunopharmacology 20061101
A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants. Immunology 20061101
Hierarchy of eosinophil chemoattractants: role of p38 mitogen-activated protein kinase. European journal of immunology 20060901
Prostanoids as pharmacological targets in COPD and asthma. European journal of pharmacology 20060308
Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. Journal of immunology (Baltimore, Md. : 1950) 20051115
CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses. European journal of pharmacology 20051107
Effects of fexofenadine hydrochloride in a guinea pig model of antigen-induced rhinitis. Pharmacology 20051001
Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2. The Journal of biological chemistry 20050916
Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2. The Journal of pharmacology and experimental therapeutics 20050701
Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists. Bioorganic & medicinal chemistry letters 20050315
Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. The Journal of pharmacology and experimental therapeutics 20050301
Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2. Molecular pharmacology 20050301
Minor structural modifications convert the dual TP/CRTH2 antagonist ramatroban into a highly selective and potent CRTH2 antagonist. Journal of medicinal chemistry 20050224
Participation of chemical mediators in the development of experimental allergic conjunctivitis in rats. International immunopharmacology 20041101
CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. International immunology 20040701
Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats. Pharmaceutical research 20040601
[Study of thromboxane A2 antagonist reduction in the treatment of patients with perennial allergic rhinitis]. Arerugi = [Allergy] 20040601
Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20040301
11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. The Journal of biological chemistry 20040227
Ramatroban (BAY u 3405): a novel dual antagonist of TXA2 receptor and CRTh2, a newly identified prostaglandin D2 receptor. Cardiovascular drug reviews 20040101
Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats. The Journal of pharmacology and experimental therapeutics 20031101
[The 3 effective cases of cough variant asthma with ramatroban]. Arerugi = [Allergy] 20031101
Ramatroban, a TP receptor antagonist, improves vascular responses to acetylcholine in hypercholesterolemic rabbits in vivo. European journal of pharmacology 20030502
An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. The Journal of pharmacology and experimental therapeutics 20030401
Ramatroban, a thromboxane A2 receptor antagonist, prevents macrophage accumulation and neointimal formation after balloon arterial injury in cholesterol-fed rabbits. Journal of cardiovascular pharmacology 20030401
The role of chemical mediators in eosinophil infiltration in allergic rhinitis in mice. International immunopharmacology 20030401
Participation of chemical mediators other than histamine in nasal allergy signs: a study using mice lacking histamine H(1) receptors. European journal of pharmacology 20020809
Thromboxane A2 inhibition: therapeutic potential in bronchial asthma. American journal of respiratory medicine : drugs, devices, and other interventions 20020101
Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins. British journal of pharmacology 20011201
[Ramatroban (Baynas): a review of its pharmacological and clinical profile]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20011201
Differential effects of prostacyclin and iloprost in the isolated carotid artery of the guinea-pig. European journal of pharmacology 20010824
Necessity of thromboxane A2 for initiation of platelet-mediated contact sensitivity: dual activation of platelets and vascular endothelial cells. Journal of immunology (Baltimore, Md. : 1950) 20010101
Synthesis and biological evaluation of new tetrahydronaphthalene derivatives as thromboxane receptor antagonists. Bioorganic & medicinal chemistry letters 19980602
Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes. Biochemical pharmacology 19920804
Properties